Levolin 50 Mcg (200mdi) Inhaler

(0 customer reviews)
Price range: $6.77 through $34.49

In Stock

Levolin 50 Mcg (200mdi) Inhaler

Price range: $6.77 through $34.49
In Stock
Secure
Checkout
Free
Shipping
30-Day
Returns
Quality
Guaranteed
Quantity
Safe Payment

All major cards & wallets accepted

Premium Quality

Tested to highest standards

24/7 Support

We're here whenever you need us

Money-Back Guarantee

30-day no questions asked

What Is Levolin 50 Mcg (200 MDI) Inhaler?

Levolin 50 Mcg (200 MDI) is a pressurised metered dose inhaler (pMDI) containing Levosalbutamol 50 mcg per actuation in an HFA (hydrofluoroalkane) propellant system. The "200 MDI" designation confirms that the canister delivers exactly 200 individually calibrated doses — making it one of the highest-count rescue inhalers available and reducing how frequently patients need to replace their device. Each metered dose is identical in concentration and volume, ensuring consistent drug delivery from the first actuation to the last. As a short-acting beta-2 agonist (SABA), Levolin works rapidly — producing bronchodilation within 5 to 15 minutes of inhalation, with peak effect between 30 and 60 minutes, and an overall duration of action of 4 to 6 hours. This pharmacological profile makes it the standard first-line rescue medication during acute asthma symptoms, sudden breathlessness, and pre-exercise bronchoconstriction prevention. Unlike maintenance controller inhalers such as ICS + LABA combinations, Levolin is used on demand rather than on a fixed twice-daily schedule.

Levosalbutamol vs Salbutamol — Why the Difference Matters

This is the most clinically important and most underexplained aspect of Levolin 50 Mcg — and it is the precise reason Cipla developed a Levosalbutamol-based inhaler rather than a standard Salbutamol product. Understanding it helps patients appreciate why their physician may have specifically prescribed Levolin over conventional Salbutamol inhalers. Conventional Salbutamol (Albuterol) is a racemic mixture — it contains two mirror-image molecular forms (enantiomers) in equal proportions:
  • R-Salbutamol (Levosalbutamol/Levalbuterol): The therapeutically active enantiomer. This is the component that binds selectively to beta-2 adrenergic receptors in bronchial smooth muscle, triggering smooth muscle relaxation, airway widening, and bronchodilation. It also possesses anti-inflammatory properties through mast cell stabilisation.
  • S-Salbutamol: The pharmacologically inactive enantiomer that contributes no bronchodilatory activity. Research has shown that S-Salbutamol is metabolised more slowly than the R-form and may, paradoxically, cause mild bronchoconstriction and inflammatory airway responses — potentially counteracting a portion of the bronchodilatory effect of the R-form in long-term users.
Levosalbutamol is the isolated, purified R-enantiomer — containing only the therapeutically active molecule. By eliminating the S-enantiomer entirely, Levolin delivers the full bronchodilatory benefit of Salbutamol at half the racemic dose (50 mcg Levosalbutamol is clinically equivalent to 100 mcg racemic Salbutamol), with a reduced cardiovascular side effect burden. The result is a cleaner pharmacological profile: equivalent bronchodilation with fewer palpitations, less tremor, and lower tachycardia at therapeutic doses — a meaningful advantage for patients with cardiovascular comorbidities, elderly patients, and children.

What Is Levolin 50 Mcg 200 MDI Inhaler Used For?

Acute Asthma Relief — The Primary Indication

Levolin 50 Mcg 200 MDI is prescribed as a reliever inhaler for the rapid reversal of acute asthma symptoms — sudden wheezing, chest tightness, breathlessness, and coughing triggered by allergens, exercise, cold air, respiratory infections, smoke, or other triggers. During an acute asthma episode, bronchospasm narrows the airway lumen, dramatically increasing airflow resistance and making breathing effortful. Levolin's rapid beta-2 receptor activation reverses this bronchospasm within minutes, restoring comfortable airflow. Important: Levolin is a reliever inhaler — it treats symptoms as they occur. It does not treat the underlying airway inflammation that causes chronic asthma. Patients with persistent asthma who require a reliever inhaler more than three times per week (outside pre-exercise use) should have their maintenance therapy reviewed by their physician — this frequency signals that disease is not adequately controlled and that a preventer inhaler such as an ICS or ICS + LABA combination is needed. Our comprehensive respiratory medications range at Ed Care Store covers both reliever and maintenance options to support a complete, balanced respiratory management plan.

COPD — Symptomatic Bronchospasm Relief

In adults with COPD — including chronic bronchitis and emphysema — Levolin 50 Mcg 200 MDI provides relief from episodic bronchospasm and acute breathlessness. While COPD is not reversible, a component of airway narrowing in COPD is bronchospastic and does respond to short-acting bronchodilators. Levolin reduces this reversible component, improving airflow and reducing the effort of breathing during symptomatic episodes. It is frequently used alongside long-acting bronchodilators and inhaled corticosteroids as part of a step-wise COPD management programme.

Exercise-Induced Bronchospasm (EIB) — Prevention

Levolin 50 Mcg 200 MDI is highly effective when taken 15 to 30 minutes before physical exercise to prevent exercise-induced bronchoconstriction. Exercise triggers rapid breathing of large volumes of relatively cool, dry air directly into the lower airways — a powerful bronchoconstriction stimulus in susceptible individuals. Pre-exercise Levolin inhalation pre-emptively relaxes bronchial smooth muscle, significantly reducing the likelihood and severity of EIB. This makes Levolin an essential inhaler for asthmatic patients who wish to participate in physical activity, sports, or exercise programmes without restriction.

Acute Asthma Attack — Emergency Relief

During a moderate acute asthma attack, Levolin 50 Mcg 200 MDI provides the fastest available bronchodilatory response achievable with a portable inhaler device. In emergency circumstances — before paramedical assistance is available — multiple actuations of Levolin via a spacer provide critical first-response airway opening. Severe, life-threatening acute attacks (status asthmaticus) require immediate emergency medical care; Levolin alone cannot substitute for nebulised bronchodilators, intravenous corticosteroids, and oxygen therapy in this context.

Mucus Clearance and Airway Ciliary Function

A less commonly highlighted but clinically recognised benefit of Levosalbutamol is its positive effect on mucociliary clearance — the self-cleaning mechanism of the airways. Beta-2 receptor stimulation by Levosalbutamol activates airway epithelial cells to increase the beat frequency of cilia lining the bronchial mucosa, accelerating the upward transport of mucus and trapped particles out of the lower airways. This action helps thin and mobilise sticky secretions that can accumulate during acute infections or exacerbations, improving airway clearance and reducing the cough burden associated with mucus pooling.

How Does Levolin 50 Mcg Inhaler Work?

Levosalbutamol is a selective short-acting beta-2 adrenergic agonist. Its bronchodilatory mechanism is direct and well-defined:
  • Levosalbutamol binds selectively to beta-2 adrenergic receptors on bronchial smooth muscle cells — the same receptors stimulated by the body's own adrenaline during the fight-or-flight response.
  • Receptor binding activates adenylyl cyclase, which converts ATP into cyclic AMP (cAMP) inside the smooth muscle cell. Rising cAMP activates protein kinase A, which phosphorylates key proteins involved in smooth muscle contraction.
  • This phosphorylation inhibits the myosin light chain kinase enzyme — the molecular switch that sustains muscle contraction. With this switch turned off, smooth muscle surrounding the bronchial walls relaxes.
  • Airway diameter increases substantially as the smooth muscle unclenches — restoring airflow, reducing wheezing, and relieving chest tightness and breathlessness within 5 to 15 minutes.
  • Mast cell membrane stabilisation: Levosalbutamol also activates beta-2 receptors on mast cells, reducing the release of histamine, prostaglandins, and leukotrienes — the chemical mediators responsible for the immediate allergic bronchoconstriction response.
The selectivity of Levosalbutamol for beta-2 receptors over beta-1 receptors (found predominantly in cardiac muscle) is the pharmacological basis for its favourable cardiovascular profile at standard doses — producing significantly less heart rate increase and palpitations than older, non-selective bronchodilators such as Isoprenaline or Adrenaline.

Levolin 50 Mcg Inhaler — Dosage and How to Use It

Recommended Dosage

  • Adults — acute symptom relief: 1 to 2 puffs (50 to 100 mcg) as needed when symptoms occur; repeat after 20 minutes if relief is insufficient, up to a maximum of 8 puffs in a 24-hour period without medical review
  • Adults — exercise-induced bronchospasm prevention: 2 puffs (100 mcg) taken 15 to 30 minutes before exercise
  • Children 4 years and above: 1 puff (50 mcg) per episode as directed by a paediatrician; always use with a spacer and appropriate face mask for children under 6 years
  • Children under 4 years: Not recommended — safety and efficacy have not been established in this age group
  • Acute severe asthma (emergency): Up to 10 puffs via a large-volume spacer every 20 minutes for up to 1 hour under medical direction — continue only until emergency medical care is available
Clinical threshold to recognise: if you are using Levolin more than three times per week for symptom relief (excluding pre-exercise doses), contact your physician. This pattern indicates your underlying asthma or COPD is not adequately controlled and that your treatment plan should be reviewed.

Step-by-Step Inhalation Technique

  • Remove the mouthpiece cap and inspect the opening for any debris; replace cap on any inhaler that has been dropped or not used recently to check for blockages
  • Shake the inhaler firmly for 5 full seconds — this re-suspends the Levosalbutamol particles in the HFA propellant for a consistent dose
  • If using for the first time or after more than 5 days without use, prime the inhaler by shaking and releasing 2 test sprays into the air away from the face
  • Breathe out slowly and as completely as comfortable — do not exhale into the mouthpiece
  • Place the mouthpiece between the teeth and form a firm, airtight seal with the lips — do not bite
  • Begin inhaling slowly and steadily through the mouth — press the canister firmly down once at the beginning of the breath — continue inhaling slowly for 3 to 5 seconds after pressing
  • Remove the inhaler from the mouth and hold the breath comfortably for 10 seconds before exhaling gently
  • Wait 30 to 60 seconds between puffs if a second actuation is prescribed — shake the inhaler again before the second puff
  • Replace the mouthpiece cap after use

Spacer Device Use — Recommended for All Patients

Clinical evidence consistently shows that using a spacer device attached to the mouthpiece increases the fraction of Levosalbutamol that reaches the lower airways by 30 to 40%. Without a spacer, a significant proportion of the aerosol cloud impacts the back of the throat before it can be inhaled — producing oropharyngeal deposition that adds nothing therapeutically but can cause throat irritation. Spacer use is particularly important for children, elderly patients, and anyone who struggles to coordinate pressing and inhaling simultaneously.

Side Effects of Levolin 50 Mcg 200 MDI Inhaler

Common Side Effects — Usually Mild and Transient

  • Tremor (fine shakiness of the hands and fingers) — a direct pharmacological beta-2 effect; usually resolves within 1 to 2 weeks of regular use as tolerance develops
  • Headache — most common at the start of treatment or after higher doses; improves with continued use
  • Palpitations — increased awareness of the heartbeat; more common with higher doses or frequent use
  • Nausea and vomiting — particularly when the drug is taken on an empty stomach
  • Throat irritation, dry mouth, and soreness — reduced by using a spacer and rinsing the mouth after each dose
  • Nasal congestion and mild pharyngitis
  • Dizziness and mild drowsiness — avoid driving or operating machinery if affected
  • Muscle tightness and cramps — from potassium shift out of cells triggered by beta-2 stimulation
  • Restlessness or mild nervousness — particularly at the start of therapy

Serious Side Effects — Seek Immediate Medical Attention

  • Paradoxical bronchospasm: Sudden worsening of wheezing and breathlessness immediately after inhalation — the opposite of the expected effect. Stop use immediately, switch to an alternative bronchodilator if available, and contact your physician urgently. This rare but real phenomenon can occur with any inhaled beta-agonist.
  • Severe hypokalaemia (critically low blood potassium): Levosalbutamol causes a dose-dependent shift of potassium from the bloodstream into cells. At standard doses this is modest and clinically insignificant in healthy patients. However, in patients with pre-existing low potassium, those on diuretics, those receiving high-dose or frequent Levolin doses, or those on xanthines (theophylline), potassium levels can fall to dangerous levels — causing muscle weakness, severe cramps, and cardiac arrhythmia. Regular potassium monitoring is advised in high-risk patients.
  • Severe chest pain: Any chest pain or pressure during or after Levolin use that does not rapidly resolve should be evaluated urgently — particularly in patients with pre-existing cardiovascular disease.
  • Seizures (fits): Rare but reported at high doses; seek immediate emergency care.
  • Severe allergic reaction (anaphylaxis): Skin rash, facial swelling, throat tightening, or acute breathing difficulty — seek emergency care immediately.
Levosalbutamol does not directly affect the eyes in standard therapeutic use. However, patients on concurrent medications that include corticosteroid eye drops or beta-blocker eye drops should inform their prescribing physician — non-selective beta-blocker eye drops (containing Timolol or Levobunolol) can antagonise Levosalbutamol's bronchodilatory effect and worsen bronchospasm in asthmatic patients. If you are managing any eye conditions alongside your respiratory therapy, our Eye Care range — including Eye Drops, Eye Gel, and Eye Care Capsules — offers a curated selection of ocular treatments for comprehensive health management.

Who Should Not Use Levolin 50 Mcg 200 MDI Inhaler?

  • Known hypersensitivity to Levosalbutamol, Salbutamol, or any component of the HFA formulation — including any prior allergic reaction to an adrenergic bronchodilator
  • Patients with a history of premature labour or threatened miscarriage — Levosalbutamol has beta-2 tocolytic (uterine relaxation) activity and should not be used during at-risk pregnancies without specialist obstetric guidance
  • Children under 4 years of age — safety and efficacy data are not established in this group
Use with caution and inform your prescribing physician if you have: cardiovascular disease, hypertension, or a history of cardiac arrhythmias — beta-2 agonists increase heart rate and may precipitate arrhythmias at higher doses; diabetes mellitus — Levosalbutamol can elevate blood glucose levels through glycogenolysis; hyperthyroidism — the thyroid gland amplifies the cardiovascular effects of adrenergic drugs; hypokalaemia — beta-2 stimulation lowers serum potassium; seizure disorders (epilepsy) — beta-2 agonists may lower seizure threshold at high doses; or severe renal impairment — Levosalbutamol is primarily renally excreted, and reduced clearance increases plasma levels and side effect risk. Respiratory disease and its management can intersect with broader health considerations for both men and women. Chronic breathlessness affects exercise tolerance, energy, and quality of life. Our Men's Health and Women's Health sections address the wider dimensions of health and wellbeing that respiratory patients often need to manage alongside their primary condition.

How to Store Levolin 50 Mcg 200 MDI Inhaler

  • Store at controlled room temperature: between 15°C and 30°C
  • Keep away from direct sunlight, heat sources, and high humidity — store in a cool, dry location; do not store in a bathroom medicine cabinet
  • Never freeze or refrigerate the inhaler — cold temperatures dramatically reduce HFA propellant pressure, resulting in insufficient dose delivery with each actuation
  • Do not expose the pressurised canister to temperatures above 49°C — the canister may burst. Never leave in a parked vehicle in warm weather, near a radiator, or in direct sunlight
  • Do not puncture, incinerate, or expose the canister to flame — even when completely empty
  • Keep the mouthpiece cap on between uses to prevent dust and debris from entering the actuator channel
  • For the most accurate dose count, check the counter on the side of the inhaler and plan ahead to replace the inhaler before it runs out — do not rely on shaking to estimate remaining doses
  • Keep out of reach of children and pets at all times
  • Do not use after the expiry date printed on the outer carton and canister label

Where to Buy Levolin 50 Mcg (200 MDI) Inhaler Online

At Ed Care Store, we are dedicated to providing genuine, properly stored Cipla medications at accessible prices — dispatched promptly and delivered with care. Levolin 50 Mcg 200 MDI Inhaler is listed alongside our complete respiratory range in the Inhalers section. Browse the full product catalogue through our Shops page, read evidence-based asthma and respiratory health content on our Blog, or get in touch with any prescription or ordering queries via our Contact page — our team is always happy to help. Please note: Levolin 50 Mcg (200 MDI) Inhaler is a Schedule H prescription-only medicine manufactured by Cipla Ltd. It must be used strictly under the supervision and guidance of a licensed healthcare professional. The content on this page is for educational reference only and does not constitute medical advice, diagnosis, or a recommendation to treat. Always follow your doctor's prescribed dosage, technique, and frequency instructions. If you are using a reliever inhaler more than three times per week for symptom relief, speak with your physician to review your overall respiratory treatment plan.
Levolin 50 Mcg (200mdi) 1 Inhaler, 3 Inhaler, 6 Inhaler
We offer free standard shipping on all orders. Orders are processed within 1-2 business days and typically arrive within 5-7 business days.
We accept returns within 30 days of purchase. Items must be in original condition with tags attached.
Yes! All our products come with a comprehensive warranty against defects in materials or workmanship.
Levolin 50 Mcg (200mdi) Inhaler
$6.77 – $34.49Price range: $6.77 through $34.49
Product zoom
EdCareStore Footer Image

Address
5954 Old Cove Heath Rd Eupora, Mississippi(MS), 39744

US Call/Text
+1 (914) 999-2631

Email
support@edcarestore.com

Trending Products

Vardenafil

Blue Pill

Tadalafil

Oral ED Jelly

Bimatoprost

Shop by category

Shop All

Men’s Health

Women’s Health

Eye Care

Asthma

Diabetes

Company

About Us

Reviews

Medicine Policy

Shipping Policy

Communication Policy

Disclaimer Policy

User guide

Indian Pharmacies

Protect Yourself

Regulated Medicine

Returns & Exchanges

Safe and Secure Shopping

FAQs

Copyright © 2026 Edcarestore | All Rights Reserved

Request Your Free Sample

Fill out the form below and our pharmacist will get in touch!

Please select an option
Full name is required
Valid phone number is required
Valid email address is required
Please describe the sample you're looking for

Thank You!

Your free sample request has been received.

Due to high demand, our pharmacist will reach out to you within the next 3-4 business days.